Colorectal

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for…

KEYPOINTS: Natco Pharma Limited has launched a novel fixed-dose combination of Trifluridine + Tipiracil for the first-time in India under the brand…